← FDA DRUG APPROVALS

FDA ANDA · ANDA208412

PREDNISONE

Sponsor: STRIDES PHARMA

APPLICATION
ANDA208412
TYPE
ANDA
ORIGINAL APPROVAL
2021-02-11
LATEST ACTION
2024-06-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PREDNISONEPrescription
PREDNISONE 20MG · TABLET · ORAL
PREDNISONEPrescription
PREDNISONE 5MG · TABLET · ORAL
PREDNISONEPrescription
PREDNISONE 50MG · TABLET · ORAL
PREDNISONEPrescription
PREDNISONE 10MG · TABLET · ORAL
PREDNISONEPrescription
PREDNISONE 2.5MG · TABLET · ORAL

Approval history

2024-06-05Labeling · Supplement 7 · standardAP
2021-02-11UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →